Compare VOR & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOR | NRIM |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.6M | 571.6M |
| IPO Year | 2021 | 2002 |
| Metric | VOR | NRIM |
|---|---|---|
| Price | $15.85 | $24.51 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $64.78 | N/A |
| AVG Volume (30 Days) | ★ 709.0K | 167.2K |
| Earning Date | 01-01-0001 | 04-24-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | 2.86 | ★ 47.44 |
| EPS | N/A | ★ 2.32 |
| Revenue | N/A | ★ $195,960,000.00 |
| Revenue This Year | N/A | $4.98 |
| Revenue Next Year | N/A | $7.40 |
| P/E Ratio | ★ N/A | $10.69 |
| Revenue Growth | N/A | ★ 23.77 |
| 52 Week Low | $0.13 | $19.60 |
| 52 Week High | $49.95 | $99.18 |
| Indicator | VOR | NRIM |
|---|---|---|
| Relative Strength Index (RSI) | 62.12 | 43.07 |
| Support Level | $11.27 | $22.46 |
| Resistance Level | $16.80 | $26.02 |
| Average True Range (ATR) | 1.23 | 0.82 |
| MACD | 0.33 | -0.02 |
| Stochastic Oscillator | 74.72 | 31.07 |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.